AminologicsLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
AminologicsLtd has a total shareholder equity of ₩56.0B and total debt of ₩1,000.0M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are ₩61.0B and ₩5.0B respectively. AminologicsLtd's EBIT is ₩1.9B making its interest coverage ratio -2. It has cash and short-term investments of ₩34.1B.
Anahtar bilgiler
1.8%
Borç/özkaynak oranı
₩1.00b
Borç
| Faiz karşılama oranı | -2x |
| Nakit | ₩34.14b |
| Eşitlik | ₩56.02b |
| Toplam yükümlülükler | ₩5.01b |
| Toplam varlıklar | ₩61.03b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
AminologicsLtd (KOSDAQ:074430) May Have Issues Allocating Its Capital
Aug 13
AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit
Mar 27Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital
Mar 01Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up
May 05Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 19If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today
Feb 04Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A074430's short term assets (₩48.5B) exceed its short term liabilities (₩4.2B).
Uzun Vadeli Yükümlülükler: A074430's short term assets (₩48.5B) exceed its long term liabilities (₩847.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A074430 has more cash than its total debt.
Borcun Azaltılması: A074430's debt to equity ratio has reduced from 1.8% to 1.8% over the past 5 years.
Borç Kapsamı: A074430's debt is well covered by operating cash flow (402.5%).
Faiz Kapsamı: A074430 earns more interest than it pays, so coverage of interest payments is not a concern.